Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy
Clinical trial NCT03373383 · COMPLETED
Trial details
- NCT number
- NCT03373383
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2020-01-30
- Enrollment
- 411
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.